Sort
141,003 grants matching “cytokine”
Exercise Response in Humans with Obesity
$669,641Ian R Lanza · Mayo Clinic Rochester · R01 · FY2024 · DK
Improved Treatment of American Cutaneous Leishmaniasis by Immunomodulation
$669,610Diane McMahon Pratt · Yale University · R01 · FY2014 · AI
Evaluation of Memory Responses and Biomarkers from a Phase IEnterotoxigenic Escherichia coli (ETEC) Intramuscular SubunitVaccine with dmLT Adjuvant
$669,587Elizabeth B Norton · Tulane University Of Louisiana · R01 · FY2021 · AI
CD103 engagement regulates intestinal IEL effector function
$669,586Tessa Bergsbaken · Rutgers Biomedical And Health Sciences · R01 · FY2024 · AI
Immune dynamics shaping blood brain barrier integrity in virally suppressed people with HIV
$669,571Leah Helane Rubin · Johns Hopkins University · R01 · FY2024 · MH
Variation in tumor-associated immune profiles and colorectal cancer outcomes
$669,492Stephanie L. Schmit · Cleveland Clinic Lerner Com-Cwru · R01 · FY2022 · CA
Endolysosomal trafficking and lipid metabolism defects in FTLD
$669,477Eric J Huang · Washington University · R01 · FY2025 · AG
Red blood cell released ATP in disturbed blood flow-initiated site specific vascular inflammation and atherosclerosis
$669,454Pingnian He · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2022 · HL
Auricular Point Acupressure to Manage Chemotherapy Induced Neuropathy
$669,413Chao Hsing Yeh · Johns Hopkins University · R01 · FY2021 · CA
Unconventional protein secretion-mediated protein quality control in health and diseases
$669,370Yihong Ye · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2022 · DK
THE ROLE OF CIRCADIAN PERIODICITY IN HUMAN CARDIOVASCULAR DISEASE AND DIABETES
$669,302John P Forman · Brigham And Women'S Hospital · R01 · FY2016 · HL
Proinflammatory B Cells Defined by TIM-4 in the Alloimmune Response
$669,277David M Rothstein · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · AI
Project 3: Role of Novel Pathways in Regulating Allogeneic Immune Responses
$669,277Bruce R. Blazar · Harvard Medical School · P01 · FY2019 · AI
Molecular and Metabolic inter-kingdom actions of a bacterial quorum sensing signal in promotion of host tolerance/resilience.
$669,269Laurence G Rahme · Massachusetts General Hospital · R01 · FY2020 · AI
Phenotypes of pathologic vertebral endplate degeneration
$669,247Jeffrey Charles Lotz · University Of California, San Francisco · R56 · FY2019 · AR
CNS Innate Immune Control of Encephalitic Flaviviruses
$669,227Michael S. Diamond · University Of Washington · U19 · FY2016 · AI
Development of safe and efficient gene therapy strategies for hemoglobinopathies
$669,194Hans-Peter Kiem · Fred Hutchinson Cancer Research Center · R01 · FY2013 · HL
Developing macrophage reprogramming mRNA nanocarriers for initial clinical testing
$669,177Matthias Stephan · Fred Hutchinson Cancer Center · R01 · FY2022 · CA
Deciphering the Mechanism of Lymphovascular Space Invasion Using a Lymphovascularized Bioengineering Breast Stromal Platform
$669,122Marissa Nichole Rylander · University Of Texas At Austin · R01 · FY2024 · CA
Dynamics of antigen specific B and Tfh responses during acute and chronic HCV
$669,100Arash Grakoui · Emory University · R01 · FY2022 · AI
Immunogenetics of Cervical and Vulvar Cancer
$669,096Fred Hutchinson Cancer Research Center · R01 · FY2005 · CA
the Gut Microbiome as a Disease Modifier of Heterotopic Ossification
$669,078Daniel S Perrien · Emory University · R01 · FY2022 · AR
Frequency and phenotype of Fel d 1-specific T cells after peptide therapy
$669,060Mark Larche · Mcmaster University · U19 · FY2014 · AI
Frequency and phenotype of Fel d 1-specific T cells after peptide therapy
$669,048Mark Larche · Mcmaster University · U19 · FY2015 · AI
Multiplexed drug testing of micro-dissected tumors using a microfluidic platform with integrated electrochemical aptasensors
$668,910Albert Folch · University Of Washington · R01 · FY2023 · CA